Masahiro Tsuchimoto

Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents

Yoshio Osada, Masahiro Tsuchimoto, Hisashi Fukushima et al. · European Journal of Pharmacology · 1993 · 166 citations

Medicine, Medicinal Chemistry, Pharmacology +6

Alendronate distributed on bone surfaces inhibits osteoclastic bone resorption in vitro and in experimental hypercalcemia models

Yoshiaki Azuma, Hiroaki Sato, Y. Oue et al. · Bone · 1995 · 142 citations

Medicine, Endocrinology, Bone Metabolism +15

Alendronate Modulates Osteogenesis of Human Osteoblastic Cells In Vitro

Masahiro Tsuchimoto, Yoshiaki Azuma, Osamu Higuchi et al. · The Japanese Journal of Pharmacology · 1994 · 80 citations · Full text

Medicine, Pharmacology, Bone Metabolism +16

PK/PD and Safety of a Single Dose of TMX‐67 (Febuxostat) in Subjects with Mild and Moderate Renal Impairment

S. Hoshide, Yoshimasa Takahashi, Takuro Ishikawa et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +15

Pharmacokinetics and Pharmacodynamics of Febuxostat (TMX‐67), a Non‐Purine Selective Inhibitor of Xanthine Oxidase/Xanthine Dehydrogenase (NPSIXO) in Patients with Gout and/or Hyperuricemia

Keiji Komoriya, S. Hoshide, Kenji Takeda et al. · Nucleosides Nucleotides & Nucleic Acids · 2004 · 40 citations

Medicine, Pharmacokinetics, Pharmacology +9